Clinical Trials
3 trialsNCT06434467 2024-05-30
The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic Lymphoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3 Unknown
NCT00406757 2017-11-13
Clinical Evaluation of Nelarabine (506U78)in Japanese Patients With Leukemia or Lymphoma
GlaxoSmithKline
Phase 1 Completed
NCT00866671 2015-01-14
Observational Study of Nelarabine in Children and Young Adults
GlaxoSmithKline
Completed